Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3604417 A
Publication typeGrant
Publication dateSep 14, 1971
Filing dateMar 31, 1970
Priority dateMar 31, 1970
Publication numberUS 3604417 A, US 3604417A, US-A-3604417, US3604417 A, US3604417A
InventorsStolzenberg Sidney Joseph
Original AssigneeAmerican Cyanamid Co, Upper Makefield Township, Wayne Henry Linkenheimer
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Osmotic fluid reservoir for osmotically activated long-term continuous injector device
US 3604417 A
Images(1)
Previous page
Next page
Description  (OCR text may contain errors)

United States Patent [72] lmcntor Sidney Joseph Stolzenberg Yardley; Wayne Henry Linkenheimer l pper Makefield Township, Bucks County.

both of. Pa;

[211 App). No 24.136

[22] Filed Mar.31,l970

[45] Patented Sept. 14. 1971 [731 Assignee American Cyanamid Company Stamford, Conn.

[54] OSMOTIC FLUID RESERVOIR FOR OSMOTIC ALLY ACTIVATED LONG-TERM CONTINUOUS INJECTOR DEVICE 2 Claims, 2 Drawing Figs.

[52] 11.8. C1 128/213, 128/225. 128/260,128/218 R, [28/218 A, 222/389 [51] Int. Cl A61m 05/00 [50] Fieldof Search 128/213,

214,215, 216, 218 R, 218 A,218 P, 225,260, 261, 1; 222/389, 399; 169/7, 27, 32, 33; 3/1

Primary Examiner-Dalton L. Truluck AttorneyNorton S. Johnson ABSTRACT: An improved osmotic pressure actuated injection device for long term continuous injection which has a chamber filled with the medicament to be injected and a suitable injection orifice, with a piston or similar device, the other side of he piston being a concentrated solution, such as a saturated solution, caPped with a semipermeable membrane and exposed to a second chamber having the solvent for the solution, and a freely movable piston exposed on its other side to atmospheric pressure or similar source so that the solvent moves through the semipermeable membrane increasing the osmotic pressure and so forcing the piston in the first chamber to discharge a small amount of medicament. The pressure in the solvent chamber is malntained constant, thus preventing formation of air pockets therein.

PATENTEU SEP'l 4191: 3604.417

INVENTORS. S/DNEY JOSEPH $7OLZENBERG WAYNE HENRY L/NKENHE/MER VMZVJW k ATTORNEY OSMOTIC FLUID RESERVOIR FOR OSMOTICALLY ACTIVATED LONG-TERM CONTINUOUS INJECTOR DEVICE BACKGROUND OF THE INVENTION Long-term, continuous injector devices have been developed for gradual administration of medicaments over a considerable time, such as the administration of anticancer agents, long continued administration of contraceptive drugs, and like, using gas pressure from electrolytic decomposition of water, which is not accurate, and also those that have been actuated by osmotic pressure. Normally the osmotic pressure devices have been supplied with flexible reservoirs, such as plastic bags and the like, and this has caused considerable problems, not only from the standpoint of size which makes it unsuitable for implanting in a patient and particularly in veterinary cases in an animal, but also, the tendency of air or gas bubbles to form as the solvent fiows out of the reservoir into the concentrated or saturated solution has resulted in a lowering of pressure so that the final pressure on the medicament became insufficient.

SUMMARY OF THE INVENTION The present invention utilizes an orifice, chamber with a piston in it containing medicament, and on the other side of the piston a concentrated or saturated solution as has been used before. However, instead of a bag containing the osmotic solvent, this is contained in another chamber which screws onto the first chamber, of course being separated from the osmotic pressure solution by a conventional semipermeable osmotic membrane, and it also contains a piston which can freely slide, the other side of the piston either being connected to atmospheric pressure or to some other constant gentle pressure so that as the osmotic solvent gradually passes through the semipermeable membrane the piston slides and prevents formation of any gas voids. Atmospheric pressure is a very desirable and simple form of maintaining the piston in continuous contact with the osmotic solvent; however, other things, such as springs or other devices, may be used.

Since the two chambers are rigid, usually of a metal or strong plastic, the operation is independent of movements of a human or animal in whom it is implanted or to whom it is attached, and this is a very important characteristic, which maintains the pressure on the osmotic solution constant for long periods of time (for example as long as 1 month or more). This assures a continuous maintenance of an unbroken layer of osmotic solvent across the membrane surface regardless of the position of the subject and no gas voids can form in the reservoir, which automatically and continuously adjusts its volume by the movement of the piston to compensate for the diminishing volume of reservoir solvent during operation of the device. A long continued, gradual release of medicament, which can be at a rate as low as 0.12 ml. per day, can be maintained, and the device of the present invention therefore avoids all of the disadvantages or drawbacks of the osmotic pressure actuated injectors used hitherto.

The nature of the material of which the two chambers are formed and of the pistons is not critical. Of course the chambers must be of a material which is compatible with mammalian tissue if it is to be implanted, but otherwise any material which is sufficiently strong to maintain its shape and freesliding fits for the two pistons may be used. For many uses, particularly where the device is attached to the patient or animal, atmospheric pressure to maintain a constant pressure on the osmotic solvent is the simplest and cheapest.

BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a section through a chamber containing the osmotic pressure solvent, and

FIG. 2 is a similar section showing the osmotic solvent chamber screwed onto the medicament dispensing chamber.

DESCRIPTION OF THE PREFERRED EMBODIMENTS The preferred embodiments will be described first generally in conjunction with the drawing followed by some specific examples giving the details of the loading and use of the instrument.

FIG. 1 shows the osmotic pressure solvent chamber at I with one chamber 2 filled with the osmotic pressure solvent and a sliding free piston 4 which is capable of sliding in the circular device. Lips 3 prevent the piston from leaving the chamber.

The chamber 2 has a threaded outlet 5 at one end, and in the modification shown in FIG. 1 an outlet to the atmosphere on the other end of the device, the chamber 6, which is on the other side of the piston 4. Connection to the atmosphere can be through any suitable conduit, such as a flexible elastomer if the device is embedded in the patient or animal. If it is desired to have a closed device, the end of the chamber 3 is closed, as is shown in dashed lines as an optional structure 7.

FIG. 2 shows the threaded opening 5 from the chamber 2 screwed onto external threads on a medicament dispensing vessel 8. This dispensing vessel contains a freely sliding piston 10, and a dispensing orifice 9 to which can be connected a short piece of hypodermic needle, a plastic or silastic tubing or similar device. The piston divides the device into two chambers, 11 and 12. The former is filled with the medicament which is to be gradually injected over a long period and the chamber 12 contains a concentrated solution of a suitable osmotic pressure developing solution, for example one constituting a saturated solution of the dyestuff Congo Red, (3,3 [4,4-biphenylenebis (azo)]bis (4-amino-l-naphthalene sulfonic acid, disodium salt). Continued saturation is provided by having some of the material present in solid form, not shown.

The chamber 12 at the end opposite the piston 10 is closed by a semipermeable membrane 14 which is clamped tightly against the end of the chamber by the clamping member 15 which shows onto a threaded shoulder 16. In the chamber 2 there is the same solvent which is used to form the solution in the chamber 12. The nature of the particular solvent is not critical as it is not contacted with the medicament or with the tissues of the patient or animal, and it may be any suitable, stable liquid. In the case of the Congo Red solution, water is a very suitable solvent. In chamber 2 water is present or, if desired, a much more dilute solution of the Congo Red. In addition to the solids mentioned above in the chamber 12, a ball of metal or noncorrodible material, such as ceramic, 17 may be provided, which will keep the saturated Congo Red solution dispersed as a result of the normal movements of the patient or animal which causes the ball to move around and to stir the solution in chamber 12 gently.

As osmotic pressure slowly and gradually builds up in chamber 12, the piston 10 moves and displaces an equal amount of medicament in chamber 11 through the orifice 9. The volume of chamber I2 of course increases as a result of the osmotic flow of solvent from chamber 2 through the semipermeable membrane 14, and a constant gentle pressure is therefore maintained on the piston 10, which results in a very slow and continuous injection of the medicament. As solvent, such as water, passes out from chamber 2 through the semipermeable membrane 14, the piston 4 moves in slightly, under atmospheric pressure in the case of this modification, or under pneumatic pressure where a closed chamber is utilized. The chamber 2, therefore, cannot develop any gas voids and there is maintained therein a gentle pressure suitable for continuous passage of solvent through the membrane. It will be noted that the piston 4 always assures that there is a constant liquid layer at the interface between the semipermeable membrane I4 and the osmotic pressure solvent in the chamber 2, and this is maintained regardless of the position of the patient or the animal in or on which the injection device is mounted.

After a long period of continuous injection, the medicament in the chamber 11 becomes exhausted and the device can then be removed from the patient or animal and after suitable cleaning and resterilizing, refilled with medicament and osmotic pressure solvent.

Where the host is immobilized it may be desirable to actuate the magnetized balls in the Congo Red compartment 12. To this end there may be provided a microtiming device, connected to two small magnets spaced exteriorly of the injector and at opposite ends of compartment 12, shown in FIG. 2. At timed intervals the balls are thus caused to roll from one end of the compartment to the other causing agitation of the Congo Red solution suspension.

EXAMPLE 1 A 2% cc. plastic disposable syringe manufactured by Becton-Dickinson, was cut off at the 2 cc. mark. The plastic handle of the piston was removed and the remaining rubber plug was placed so that the syringe would hold a volume of 1 cc. of medicament. The remainder of the syringe contained about 0.8 gm. Congo Red and two stainless steel balls. This was covered by a sheet of semipermeable membrane obtained from a Visking dialysis sac. The membrane covered this opening tightly and the ends were folded back securely. A hollow cylinder obtained from a 5 cc. syringe of the same type, out between the and 3 cc. marks, was inserted over the ends of the semipermeable membrane. An airtight seal was made between the two plastic syringes with Dow-Corning medical grade Elastomer. The Elastomer hardened with a few minutes and supported the semipermeable membrane as well. At the other end of the cylinder the rubber plug from the 5 cc. syringe was inserted and the opening behind the plug was covered with a plastic cap with a small opening in the center. The plastic cap was sealed in place behind the 5 cc. syringe with Elastomer.

To activate the device, two hypodermic needles were inserted through the plastic walls on each side of the semipermeable membrane. These were filled with distilled water so as to exclude air bubbles on either side. The holes caused by the hypodermic needles were sealed with elastomer. The compartment designed to hold the medicament was filled with a 0.] percent methylene blue solution by means of a thin caliber hypodermic needle inserted through the opening.

The device successfully constructed was tested in an in vitro system. It was warmed at 37 C. in a water bath contained in a Dubnoff shaker. The entire 1 cc. of methylene blue was expelled within 2% to 3 hours. When a plastic ring was glued next to the semipermeable membrane such that the diameter of the membrane exposed to fluids was about 3 mm., less than I cc. of the methylene blue solution was injected after a week. It was about 0.12 cc. of solution was expelled per day. The decline in volume of methylene blue could be observed from day to day.

EXAMPLE 2 It should be emphasized that a high purity Congo Red, free of contaminating ions or compounds of low molecular weight, is essential, Contaminating molecules diffuse across the semipermeable membrane and nullify or reduce the effective osmotic gradient.

The device is constructed as shown in FIG. 2 However, a percent solution suspension of Congo Red is used. In our recent experiments higher concentrations tended to congeal and eventually appeared gelatinous. The Congo Red compart ment was filled and five stainless steel balls of about 1.5 mm. diameter were added. The compartment was covered with a Visking semipermeable membrane with a thickness of 0.0008 inch. The water compartment obtained from a 5 cc. syringe was sealed in place as previously described, using Caulk Grip dental cement instead of Elastomer. Two drops of distilled water was added and the water compartment was covered with the rubber plunger from the 5 cc. syringe for storage before use.

To activate an injector device, the rubber plunger was removed and the water compartment filled with distilled water. A 24-gauge hypodermic needle was inserted through the plunger. The plunger was reinserted into the 5 cc. syringe, allowing the excess water to flow out through the hypodermic needle. Both the Congo Red and water compartments were free of air bubbles. The opening behind the plug was covered with a snugly fitting plastic cap with an opening in the center measuring about 3 mm. in diameter. The medicament compartment was filled with water.

Two in vitro experiments were carried out in a Dubnoff shaker by placing the devices in a water bath at 37 with mild but continuous agitation. The results obtained with six injector devices are listed in table 1. Two injector devices were fastened on the backs of two sheep in an area previously shaved to remove the wool. The devices were held in place with adhesive tape and branding cement. The results are shown in table 2.

TABLE 1 Injector N 0.

Day Time 1 1 2 1 3 1 1 0900 1. 03 1. 03 1.03 1030 0. 95 0. 9O 0. 88 1115 0. 0.83 0. 78 1215 0. T5 0. 70 0. 67 1325 O. 65 0. 63 0. 58 1520 0. 50 0. 50 0. 45 1630 0. 45 0. 43 0 37 M1. solution remaining in medicament compartment.

2 There was a large bubble in water compartment observed at this time which probably lnterferred with osmosis.

M1. solution remaining in medicament compartment.

We claim:

1. in a continuous, long-term injector device, which comprises a hollow member with injection orifice at one end adapted for connection with body tissue, a slidable piston in the member dividing it into first and second chambers and a semipermeable membrane across the end of said second chamber, the second chamber being filled with an osmotic pressure developing solution and the 69 chamber containing a medicament, the improvement which comprises,

a. a second hollow member serving as a reservoir for osmotic pressure solvent and provided with a freely sliding piston,

b. screw-threaded means securing the reservoir onto the hollow member of the injector device to maintain continuous contact of the osmotic pressure solvent with the semipermeable membrane, and

2. A injector device according to claim 1 in which the source of at least ambient pressure is the atmosphere.

UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Patent No. 5,604,417 Dated September 14, 1971 Inventor) Sidney Joseph Stolzenberg & Wayne Henry Linkenheimer It is certified that error appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:

Abstract of the Disclosure, line 5, "he" should read the Abstract of the Disclosure, line 6, "caPped" should read capped Abstract of the Disclosure, line 15, "maIntained" should read maintained Column 1, line 12 "and like" should read and the like Column 2, line 58 "shows' should read screws Column 5, line 5 after "medicament" insert and osmotic pressure developing solution Column 5, line 59 should read after essential.

Column 4, line 6'? "69" should read first Signed and sealed this 18th day of April 1972.

{ EAL) l L to s L EDWARD ILFIJSICIHERJR. ROBERT GOTTSCHALK A ttesting Officer Commissioner of Patents QM PO-1050H0-69) USCOMM-DC 60376-F'B9 Q U 5 GOVERNMENT FRINHNG OFFICE I969 0366334

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2690178 *Nov 13, 1950Sep 28, 1954Research CorpAutomatic apparatus for administering drugs
US3023750 *Mar 4, 1959Mar 6, 1962Howard C BaronSelf-generating pressure device for infusion administration systems
US3211431 *Sep 27, 1961Oct 12, 1965David M MeysembourgMethod and apparatus for compounding desired concentrations
US3214067 *Sep 11, 1962Oct 26, 1965Linington Thomas RFluid dispenser
US3313289 *Jun 23, 1964Apr 11, 1967Kapral Frank AImplant chamber
US3367545 *Sep 15, 1965Feb 6, 1968Products Res & Chemical CorpGas-generating dispenser for viscous materials
US3527220 *Jun 28, 1968Sep 8, 1970Fairchild Hiller CorpImplantable drug administrator
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3732865 *Jan 13, 1971May 15, 1973Alza CorpOsmotic dispenser
US3760804 *Jan 13, 1971Sep 25, 1973Alza CorpImproved osmotic dispenser employing magnesium sulphate and magnesium chloride
US3760806 *Jan 13, 1971Sep 25, 1973Alza CorpHelical osmotic dispenser with non-planar membrane
US3760984 *Sep 29, 1971Sep 25, 1973Alza CorpOsmotically powered agent dispensing device with filling means
US3786813 *Dec 27, 1972Jan 22, 1974Alza CorpDrug delivery device with self actuated mechanism for retaining device in selected area
US3788322 *Dec 27, 1972Jan 29, 1974Alza CorpDrug delivery device with means for maintaining device in environment of use
US3797492 *Dec 27, 1972Mar 19, 1974Alza CorpDevice for dispensing product with directional guidance member
US3894538 *Aug 6, 1973Jul 15, 1975Siemens AgDevice for supplying medicines
US3896819 *Sep 30, 1971Jul 29, 1975Alza CorpIUD having a replenishing drug reservoir
US3929132 *Jul 23, 1974Dec 30, 1975Alza CorpOsmotic dispenser
US3987790 *Oct 1, 1975Oct 26, 1976Alza CorporationOsmotically driven fluid dispenser
US3995631 *Sep 25, 1972Dec 7, 1976Alza CorporationOsmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3995632 *Sep 30, 1974Dec 7, 1976Alza CorporationOsmotic dispenser
US4034756 *Mar 12, 1976Jul 12, 1977Alza CorporationOsmotically driven fluid dispenser
US4036228 *Sep 11, 1975Jul 19, 1977Alza CorporationOsmotic dispenser with gas generating means
US4147282 *Jun 6, 1977Apr 3, 1979Sidney LevyVacuum actuated pressurized fluid dispenser
US4209014 *Dec 12, 1977Jun 24, 1980Canadian Patents And Development LimitedDispensing device for medicaments
US4340048 *Mar 28, 1981Jul 20, 1982Alza CorporationSelf-driven hypodermic injector
US4384581 *Aug 18, 1981May 24, 1983Becton, Dickinson And CompanyMicrosyringe
US4474575 *Sep 22, 1982Oct 2, 1984Alza CorporationSelf-driven pump assembly and method of operation
US4505701 *May 17, 1982Mar 19, 1985Navato Jose RAutomatic parenteral infusion apparatus
US4539004 *Apr 23, 1984Sep 3, 1985Alza CorporationSelf-driven pump assembly and method of operation
US4623330 *Feb 16, 1983Nov 18, 1986Laby Ralph HGas diffusion-limited controlled release devices
US4781688 *Apr 6, 1987Nov 1, 1988Herwig ThomaDispensing device for a liquid medicament
US4838862 *Aug 4, 1986Jun 13, 1989Pharmetrix Corp.Portable controlled release osmotic infusion device
US5135500 *Oct 31, 1989Aug 4, 1992Prime Medical Products, Inc.Self-driven pump device
US5151093 *Oct 29, 1990Sep 29, 1992Alza CorporationOsmotically driven syringe with programmable agent delivery
US5234424 *Dec 18, 1989Aug 10, 1993Alza CorporationOsmotically driven syringe
US5279608 *Dec 4, 1991Jan 18, 1994Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.)Osmotic pumps
US5312389 *Apr 3, 1992May 17, 1994Felix TheeuwesOsmotically driven syringe with programmable agent delivery
US5341993 *Dec 21, 1992Aug 30, 1994Habley Hills Technology CorporationTopical sprayer with remotely actuated spray tip
US5540665 *Jan 31, 1994Jul 30, 1996Alza CorporationGas driven dispensing device and gas generating engine therefor
US5651979 *Jun 7, 1995Jul 29, 1997Gel Sciences, Inc.Apparatus and method for delivering a biologically active compound into a biological environment
US5935593 *Oct 22, 1996Aug 10, 1999Medlogic Global CorporationChemo-mechanical expansion delivery system
US6575930Mar 12, 1999Jun 10, 2003Medrad, Inc.Agitation devices and dispensing systems incorporating such agitation devices
US6632217 *Apr 19, 2001Oct 14, 2003Microsolutions, Inc.Implantable osmotic pump
US6652489 *Feb 5, 2001Nov 25, 2003Medrad, Inc.Front-loading medical injector and syringes, syringe interfaces, syringe adapters and syringe plungers for use therewith
US6706020Aug 26, 1999Mar 16, 2004Schering AktiengesellschaftSyringes and injectors incorporating magnetic fluid agitation devices
US6733478Nov 4, 2002May 11, 2004Medrad, Inc.System and method for providing information from a syringe to an injector
US6775570Apr 18, 2002Aug 10, 2004Ceramatec, Inc.Iontophoretic treatment device
US6808513Jun 10, 2002Oct 26, 2004Medrad, Inc.Front loading medical injector and syringe for use therewith
US6958053Nov 24, 1999Oct 25, 2005Medrad, Inc.Injector providing drive member advancement and engagement with syringe plunger, and method of connecting a syringe to an injector
US6966894Aug 26, 1999Nov 22, 2005Schering AktiengesellschaftSyringes and injectors incorporating mechanical fluid agitation devices
US6977074Feb 2, 2001Dec 20, 2005Mannkind Corporationto an antigen by sustained release to the lymphatic system; cytotoxic T lymphocytes; immunization; drug delivery
US6994851Jul 10, 1998Feb 7, 2006Mannkind Corporationcytotoxic T-lymphocyte (CTL) response; comprises placing a physiologically-acceptable, antigen-containing composition in a reservoir having a pump for delivering the composition at a defined rate through a transmission line
US7047069Feb 4, 2002May 16, 2006Ceramatec, Inc.Iontophoretic fluid delivery device
US7060049May 12, 2003Jun 13, 2006Medrad, Inc.Injection system having an agitation mechanism for circulating a fluid medium
US7081105Aug 5, 2004Jul 25, 2006Medrad, Inc.Injector system having a front loading pressure jacket assembly
US7103977Aug 19, 2003Sep 12, 2006Eveready Battery Company, Inc.Razor having a microfluidic shaving aid delivery system and method of ejecting shaving aid
US7349733Nov 2, 2001Mar 25, 2008Ceramatel, Inc.Iontophoretic drug delivery systems
US7351221Mar 31, 2006Apr 1, 2008Medrad, Inc.Container for agitating and injecting a multi-component medium
US7364729Dec 19, 2005Apr 29, 2008Mannkind CorporationMethod of inducing a CTL response
US7419478Jun 25, 2003Sep 2, 2008Medrad, Inc.Front-loading syringe for medical injector having a flexible syringe retaining ring
US7540856Sep 23, 2003Jun 2, 2009Medrad, Inc.Front-loading medical injector adapted to releasably engage a syringe regardless of the orientation of the syringe with respect to the injector
US7553294May 30, 2002Jun 30, 2009Medrad, Inc.Syringe plunger sensing mechanism for a medical injector
US7611473Sep 11, 2003Nov 3, 2009Ethicon, Inc.Tissue extraction and maceration device
US7718047Oct 18, 2005May 18, 2010The Regents Of The University Of Coloradoelectrochemical pumps produce changes in pressure and/or volume of electrolyte solution or ionic liquid associated with at least one compartment of an electrochemical cell; these pressure and/or volume changes can then be used to drive flow of electrolyte solution or ionic liquid or flow of other fluid
US7794408 *Mar 28, 2003Sep 14, 2010Ethicon, Inc.Tissue collection device and methods
US7998086Sep 29, 2009Aug 16, 2011Depuy Mitek, Inc.Tissue extraction and maceration device
US8034003Mar 27, 2008Oct 11, 2011Depuy Mitek, Inc.Tissue extraction and collection device
US8133203May 19, 2009Mar 13, 2012Medrad, Inc.Method of injecting fluids from a dual syringe injector system
US8197844Jun 8, 2007Jun 12, 2012Activatek, Inc.Active electrode for transdermal medicament administration
US8322993Nov 10, 2008Dec 4, 2012Acuros GmbhOsmotic pump comprising a pressure device for pressurizing the solvent
US8372393May 3, 2006Feb 12, 2013Mannkind CorporationMethod of inducing a CTL response
US8562542Jul 15, 2010Oct 22, 2013Depuy Mitek, LlcTissue collection device and methods
US8574200Mar 12, 2012Nov 5, 2013Medrad, Inc.Dual syringe injector system
US8585610Jun 28, 2011Nov 19, 2013Depuy Mitek, LlcTissue extraction and maceration device
US8617123Aug 20, 2010Dec 31, 2013Becton Dickinson France, S.A.S.Pre-filled active vial having integral plunger assembly
US8715480May 2, 2012May 6, 2014Eksigent Technologies, LlcElectrokinetic pump having capacitive electrodes
US8721596Sep 23, 2003May 13, 2014Bayer Medical Care Inc.Front-loading syringe adapted to releasably engage a medical injector regardless of the orientation of the syringe with respect to the injector
US20070148014 *Nov 22, 2006Jun 28, 2007Anex Deon SElectrokinetic pump designs and drug delivery systems
DE4141819B4 *Dec 18, 1991Aug 19, 2004Société de Conseils de Recherches et D'Applications Scientifiques (S.C.R.A.S.)Osmotische Pumpe
EP0235691A2 *Feb 19, 1987Sep 9, 1987Hoechst AktiengesellschaftDevice for dispensing medicinal suspensions
EP0259013A1Aug 4, 1987Mar 9, 1988Pharmetrix CorporationPortable controlled release osmotic infusion device
EP0354742A2 *Aug 4, 1989Feb 14, 1990Pharmetrix CorporationPortable infusion device assembly
EP0398397A1 *Feb 19, 1987Nov 22, 1990Hoechst AktiengesellschaftUtilisation of the device for dispensing medical suspensions and procedure to obtain a homogeneous mixture of this suspension
EP2060286A1 *Nov 13, 2007May 20, 2009Acuros GmbHOsmotic pump
WO1981001794A1 *Dec 24, 1980Jul 9, 1981S AshSystem for demand-based administration of insulin
WO2002085428A2 *Apr 3, 2002Oct 31, 2002Microsolutions IncImplantable osmotic pump
WO2004011062A1 *Jul 24, 2003Feb 5, 2004Cris CatalinAdministration device comprising an osmotic drive
Classifications
U.S. Classification604/131, 604/143, 222/389
International ClassificationA61M3/00, A61M5/145
Cooperative ClassificationA61M5/145, A61M3/00, A61M5/14526, A61M2005/14513
European ClassificationA61M3/00, A61M5/145B2, A61M5/145